ACR Meeting Abstracts

ACR Meeting Abstracts

Session » RA – Treatments II: Potential Harms & Adverse Events (1998–2002)

Date: Monday, November 9, 2020

Time: 3:00PM-3:50PM

Meeting: ACR Convergence 2020

Abstract Number: 1998
Ten-year Analysis of the Risk of Severe Outcomes Related to Very Low-dose Glucocorticoids in Early Rheumatoid Arthritis
Abstract Number: 1999
Hydroxychloroquine Is Not Cardiotoxic in Patients with Rheumatoid Arthritis
Abstract Number: 2000
Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine
Abstract Number: 2001
Adverse Effects of Low Dose Methotrexate: Adjudicated Hematologic Outcomes in a Large Randomized Double-blind Placebo-controlled Trial
Abstract Number: 2002
Incidence and Risk Factors for Herpes Zoster in Rheumatoid Arthritis Patients Receiving Upadacitinib

« View all sessions from this meeting